ABBV AbbVie Inc. | US00287Y1091
| Metric | Current | 31.03.2026 | 31.12.2025 | 30.09.2025 |
|---|---|---|---|---|
| Market Cap | 458.235.346.944 | 384.246.593.055,58 | 403.942.004.948,38 | 409.212.178.886,37 |
| Enterprise Value | 521.800.384.512 | 447.713.593.055,58 | 466.209.004.948,38 | 472.326.178.886,37 |
| Trailing P/E | 126,52 | 105,71 | 95,58 | 169,8 |
| Forward P/E | 15,92 | - | - | - |
| Price to Sales | 7,29 | 6,12 | 6,6 | 9,19 |
| Price to Book | - | - | - | - |
| EV/Revenue | 8,31 | 7,13 | 7,62 | 10,6 |
| EV/EBITDA | 17,44 | 19,91 | 20,54 | 29,42 |